- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01701128
The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease
October 3, 2012 updated by: Laval University
The Effect of Exercise Training on Gait and Quality of Life in Patients With Early Parkinson's Disease
The project aims to evaluate the effects of 24 weeks of treadmill training (TT), with and without a strengthening component, on functional mobility, gait and quality of life in patients with Parkinson's disease (PD).
The rationale for a study of this type stems from the hypothesis that treadmill training may act as an external "pacemaker" and enhance some properties of gait.
There is a need for larger scale randomized controlled trials comparing the effects of treadmill training to control groups that receive similar amounts of attention.
To date, no study has combined TT and muscle strengthening, likely the optimal form of therapy.
A kinesiologist supervises the training, 3 times per week, for a total of 72 one-hour exercise sessions.
It is hypothesized that at the end of 6 months, treadmill training will considerably improve walking parameters and the well being of people with PD.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Quebec, Canada, G1V 0A6
- Laval University
-
Quebec, Canada, G1S 2M5
- Quebec Memory and Motor Skills Disorders Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's disease
- Stage of II or less on Hoehn and Yahr scale
Exclusion Criteria:
- Having musculoskeletal impairments or having excessive pain in any joint that could limit participation in exercise program
- Dementia (MMSE<24)
- Having balance problems
- Live beyond 45 minutes from Laval University
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Speed TT
Walk on treadmill with progressive increases in speed
|
3 sessions/week, 24 weeks.
The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg.
During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant.
The following week, the participant was encouraged to reach 90% and 100% in the third week.
From the fourth week, subjects in the Speed TT had an increase in speed, depending on exercise tolerance of each participant.
The TT velocity was increased by 0,2 km/h when the participant reached criteria.
3 sessions/week, 24 weeks.
The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg.
During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant.
The following week, the participant was encouraged to reach 90% and 100% in the third week.
From the fourth week, the TT velocity was increased by 0,2 km/h or the incline of the walking surface of TT was increased by 1% alternately when the progression criteria were met.
|
|
Experimental: Mixed TT
Walk on treadmill with progressive increases in speed and incline
|
3 sessions/week, 24 weeks.
The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg.
During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant.
The following week, the participant was encouraged to reach 90% and 100% in the third week.
From the fourth week, subjects in the Speed TT had an increase in speed, depending on exercise tolerance of each participant.
The TT velocity was increased by 0,2 km/h when the participant reached criteria.
3 sessions/week, 24 weeks.
The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg.
During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant.
The following week, the participant was encouraged to reach 90% and 100% in the third week.
From the fourth week, the TT velocity was increased by 0,2 km/h or the incline of the walking surface of TT was increased by 1% alternately when the progression criteria were met.
|
|
Active Comparator: Control
Light-intensity exercise group, work flexibility and coordination
|
Training of the control group was characterized by light intensity exercises.
For the first three months, participants performed regular exercise involving full range of motion to enhance their flexibility.
For the last three months of the training programme, participants learned elements of Tai Chi and rhythmic movements of latin dance.
Participants attended two 1-h supervised sessions per week and were asked to perform each week a third session at home, based on instructions in a document offered to the control group participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Gait speed
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using the GAITrite system
|
Baseline, 3 and 6 months
|
|
Change in Endurance walking
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using the 6-minutes walk test
|
Baseline, 3 and 6 months
|
|
Change in Quality of life
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using PDQ-39
|
Baseline, 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Postural Balance
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using force platform PRO Balance Master®
|
Baseline, 3 and 6 months
|
|
Change in Spatiotemporal parameters of walking
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using the GAITrite system
|
Baseline, 3 and 6 months
|
|
Change in Cognitive impairment
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using Mini-Mental State Examination
|
Baseline, 3 and 6 months
|
|
Change in Fear of falling
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using the ABC Scale
|
Baseline, 3 and 6 months
|
|
Change in Depression and anxiety level
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using BDI-II
|
Baseline, 3 and 6 months
|
|
Change in Effects of symptoms and motor impairment
Time Frame: Baseline, 3 and 6 months
|
This measure was recorded using the UPDRS
|
Baseline, 3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Philippe Corbeil, Laval University
- Study Director: Alexandra Nadeau, Laval University
- Principal Investigator: Emmanuelle Pourcher, Quebec Memory and Motor Skills Disorders Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
September 18, 2012
First Submitted That Met QC Criteria
October 3, 2012
First Posted (Estimate)
October 4, 2012
Study Record Updates
Last Update Posted (Estimate)
October 4, 2012
Last Update Submitted That Met QC Criteria
October 3, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TTPD-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Universitätsklinikum Hamburg-EppendorfUniversity of Oxford; University of TwenteRecruitingDeep Brain Stimulation | Parkinson's Disease (PD)Germany
Clinical Trials on Walking on treadmill
-
Atlas UniversityCompletedFatigue | Autonomous Nervous SystemTurkey
-
University Hospital, GhentUniversity GhentRecruiting
-
Hacettepe UniversityUnknownAmputation | Gait | Dual TaskTurkey
-
University Hospital, GhentUniversity Ghent; Vrije Universiteit Brussel; VU University of AmsterdamRecruiting
-
Nantes University HospitalCompleted
-
Hopital FochCompletedWalking, DifficultyFrance
-
Meuhedet. Healthcare OrganizationCompleted
-
Samsung Medical CenterCompletedStroke | Gait Disorders, NeurologicKorea, Republic of
-
University of Arkansas, FayettevilleRecruitingDiabetes Mellitus, Type 2United States
-
Alyn Pediatric & Adolescent Rehabilitation HospitalCompletedCerebral Palsy | Traumatic Brain InjuryIsrael